Pitch 1-8 : Yasumichi Hitoshi, Thyas Co. Ltd.

P-8 Thyas.pngThyas Hitoshi trimming.jpg

Dr. Hitoshi will pitch in Pitch Session 1!
等氏はPitch Session 1に登壇予定!

Pitch Title

Fighting Cancer with Nobel Prize-winning iPS Cell Technology


Yasumichi Hitoshi

President & CEO, Thyas Co. Ltd.

等 泰道 氏
サイアス㈱ 代表取締役社長

Speaker Profile Dr. Hitoshi obtained a MD degree and acquired PhD in immunology. He is familiar with immunology, cytokine signaling, immuno-oncology, cancer metabolism, metabolic diseases, and retroviral transduction systems. He has >15 year experience with heading oncology and metabolism researches (Target identification and validation, preclinical development of small molecule therapeutics) as a research director. He was involved in the IND filling process of multiple drugs.


HVC KYOTO 2018 will be held on July 3rd 2018!

Click here for the program.

To attend the event, please fill out the form from here!


HVC KYOTO 2018は2018/7/3に開催いたします。

当日のプログラムは こちら をご覧ください。

HVC KYOTO 2018への参加お申し込みは こちら から。